Jakmac-ER Tablet
Jakmac-ER Tablet
Tofacitinib (11mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Jakmac-ER Tablet: A Powerful Treatment Option for Moderate to Severe Plaque Psoriasis
Jakmac-ER tablet, containing the active ingredient Tofacitinib 11mg, is a prescription medication used for treating moderate to severe plaque psoriasis in adults. This once-daily oral formulation provides effective relief from symptoms such as redness, itching, and scaling of affected skin.
Tofacitinib works by inhibiting specific immune pathways involved in the inflammatory response that contributes to psoriasis development. It reduces the production of proinflammatory cytokines, thereby slowing down the progression of the condition. Jakmac-ER tablet's effectiveness has been demonstrated through clinical trials in various patient populations.
Before starting treatment with Jakmac-ER, consult with a healthcare professional to determine if it is appropriate for your individual needs and to address any potential risks or side effects. This medication should not be used by pregnant or breastfeeding women, individuals with certain autoimmune disorders, or those taking specific medications due to potential interactions.
Note: This information is intended for general understanding only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new treatment.
Active composition
Tofacitinib 11 mg
About Tofacitinib
Tofacitinib is a Janus kinase inhibitor used to treat rheumatoid arthritis and ulcerative colitis. It works by blocking inflammatory pathways, reducing symptoms and disease activity. This medication is crucial for managing autoimmune conditions. In summary, Tofacitinib is effective in treating rheumatoid arthritis and ulcerative colitis.
How It Works
Tofacitinib inhibits Janus kinases, disrupting signaling pathways involved in inflammation and immune responses.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jakmac-ER Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jakmac-ER Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jakmac-ER Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Jakmac-ER Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Jakmac-ER Tablet does not usually affect your ability to drive.
Consult Doctor
Kidney
Jakmac-ER Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Jakmac-ER Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jakmac-ER Tablet